EDUCATIONAL LEARNING OBJECTIVES:

• Differentiate between generic drugs and biosimilars.
• Describe the FDA approval criteria for biosimilars.
• Comprehend the factors driving adoption of biosimilars in the home infusion site of care.
• Describe the role of the home infusion pharmacy in facilitating adoption of biosimilars in their patient populations.